Polyphron raises backing to build the verification substrate for AI drug discovery
darian314 · x · 2026-09-17
An investor announced backing for Polyphron, a startup building a "verification substrate" for biology. The thesis: AI models excel in strongly verifiable domains like math and code, and the team (Matthew Osman, FabioZB and co.) aims to bring that verifiability to drug discovery.
More from Venture
- Cross-Platform Arbitrage: Reddit Lags X by Days on AI News, Says Poster — TheMoonMidas · 2026-09-18
- Instinct's fundraising order is the reverse of the classic Benchmark-to-Greenoaks path — bosmeny · 2026-09-18
- Beacon Acquires AI Red-Teaming Startup Haize Labs; Founder Leonard Tang Becomes VP of AI Research — Jackyhuang · 2026-09-18
- Ex-DeepMind founders' UK AI startup in talks for a $700M seed round — nmasc_ · 2026-09-18
- Robotics startup Watney raises $80M to expand data-center-building robot fleet — Polymarket · 2026-09-18
- Oracle: renewed GPUs fetched 20% premium in Q1, most 4+ years old — Beth_Kindig · 2026-09-18